APHA - Dividend announcements

Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business LEAMINGTON, ON, April 12, 2021 /CNW/ - Aphria Inc. ("Aphria," "we," or the "Company") (TSX:APHA) (NASDAQ:APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business LEAMINGTON, ON, April 12, 2021 /PRNewswire/ - Aphria Inc. ("Aphria," "we," or the "Company") (TSX:APHA) (NASDAQ:APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

NEW YORK, Feb. 11, 2021 /PRNewswire/ -- The legalization of medical cannabis and its decriminalization in certain countries has led to a significant decrease in the black market. People are now choosing to legally purchase their cannabis for medical as well as adult use. Typically, medical marijuana is used for the treatment of chronic conditions, such as cancer, arthritis, and neurological conditions, such as anxiety, depression, epilepsy, as well as Parkinson's, and Alzheimer's disease. In the U.S, New Jersey became the most recent state where two key legislative budget committees advanced a recreational cannabis implementation measure. New Jersey voters legalized an adult-use marijuana